SODIUM PHOSPHATES

Generic: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Fresenius Kabi USAManufacturer
INTRAVENOUSRoute
SODIUM PHOSPHATEActive Substance
2022-03-30Original Approval

SODIUM PHOSPHATES is FDA application ANDA209997, sponsored by FRESENIUS KABI USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
ASTHENIA
19 reports
2
DIARRHOEA
19 reports
3
RENAL FAILURE ACUTE
19 reports
4
NAUSEA
18 reports
5
CONSTIPATION
16 reports
6
DEHYDRATION
14 reports
7
FALL
14 reports
8
PYREXIA
14 reports
9
VOMITING
14 reports
10
DIZZINESS
13 reports